FeesSafety
Pluang+

FDA grants YD Bio early regulatory feedback for dry eye disease biologic candidate

Market News
12 Nov 2026, 23:30 WIB
GlobeNewsWire
View Source
Bullish
FDA grants YD Bio early regulatory feedback for dry eye disease biologic candidate

YD Bio Limited received FDA approval for an INTERACT meeting to get early written guidance on YDB-LMSCEV-001, its investigational eye drop for moderate-to-severe dry eye disease. This biologic uses extracellular vesicles derived from donor stem cells. The FDA will provide feedback by January 4, 2027, focusing on manufacturing and preclinical study design, helping YD Bio prepare for human clinical trials. This early regulatory engagement is crucial for developing this novel therapy class.

YD Bio's FDA INTERACT meeting approval is the story's subject. For readers following the health sector, here is Pluang's market snapshot as of Nov 13, 2026 04:11 WIB: out of 150 priced US health stocks, 23 rose and 124 fell. Notable movers include NUWE at USD 5.11 with a -7.59% change and 100% sell order activity, Moderna at USD 230.95 with a -7.13% change, and Butterfly Network at USD 6.64 with a -7.00% change.

More News

ASUS launches AI-ready hardware and software for gamers, creators, and enterprises with local, cloud, and hybrid AI options.

ASUS launches AI-ready hardware and software for gamers, creators, and enterprises with local, cloud, and hybrid AI options.

ASUS has introduced a broad ecosystem of AI-ready hardware and software designed for gamers, creators, developers, and enterprises. The ASUS Agent Computer initiative enables users to deploy AI locally, in the cloud, or via hybrid models, offering co...

Market News
Bullish
2 hours ago
Cosmetic peptide synthesis market to reach $355M by 2032, driven by anti-aging skincare demand and tech advances.

Cosmetic peptide synthesis market to reach $355M by 2032, driven by anti-aging skincare demand and tech advances.

The global cosmetic peptide synthesis market is projected to grow from $274 million in 2027 to $354.85 million by 2032, with a CAGR of 5.34%. Growth is fueled by rising demand for advanced anti-aging skincare ingredients, increased use of peptide-bas...

Market News
Bullish
2 hours ago
Cisco Q1 2027 earnings focus on cloud and AI with revenue expected at $18.1B and EPS $1.33

Cisco Q1 2027 earnings focus on cloud and AI with revenue expected at $18.1B and EPS $1.33

Cisco is set to report its fiscal Q1 2027 earnings with a focus on cloud growth and AI demand. Analysts expect revenue around $18.1 billion, operating income of $6.5 billion, and earnings per share of $1.33, reflecting strong year-over-year growth. T...

Company Fundamentals
Neutral
2 hours ago
BASF to sell its mining solutions business to SNF, deal expected to close in 2027.

BASF to sell its mining solutions business to SNF, deal expected to close in 2027.

BASF has agreed to sell its global mining solutions business to SNF, a specialty chemical company based in France, following a strategic review of BASF's Performance Chemicals division. The deal includes BASF's mining chemicals portfolio, production ...

Company Fundamentals
Neutral
3 hours ago
TDG Gold sells 51% of Aurora West project to Freeport for C$110M, with potential for Freeport to increase stake.

TDG Gold sells 51% of Aurora West project to Freeport for C$110M, with potential for Freeport to increase stake.

TDG Gold Corp. has agreed to sell a 51% interest in its Aurora West property to Freeport-McMoRan for C$110 million in cash. Freeport also has an option to increase its ownership to 75% or 100% by funding an additional C$80 million in exploration and ...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App